project id: TCGA-MESO; case submitter id: TCGA-TS-A8AS; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.45; rna integrity number: 7.8; age at index: 77; days to birth: -28273; days to death: 795; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1934; year of death: 2013; age at diagnosis: 28273; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 692; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-TS-A8AS-01A-21; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;